ECL
ECL
Ecolab Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $4.2B ▲ | $1.06B ▼ | $563.9M ▼ | 13.44% ▼ | $2 ▼ | $903.4M ▲ |
| Q3-2025 | $4.17B ▲ | $1.11B ▲ | $585M ▲ | 14.05% ▲ | $2.06 ▲ | $789M ▼ |
| Q2-2025 | $4.03B ▲ | $1.09B ▲ | $524.2M ▲ | 13.02% ▲ | $1.85 ▲ | $977.8M ▲ |
| Q1-2025 | $3.69B ▼ | $1.05B ▼ | $402.5M ▼ | 10.89% ▼ | $1.42 ▼ | $818.2M ▼ |
| Q4-2024 | $4.01B | $1.05B | $472.9M | 11.81% | $1.67 | $848.5M |
What's going well?
The company is keeping revenue stable and managing costs well, with operating expenses down and operating profit up. Interest costs are falling, and the business remains solidly profitable.
What's concerning?
Gross margins are slipping, and net income is down despite cost cuts. Growth is nearly flat, and higher 'other' expenses are weighing on the bottom line.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $646.2M ▼ | $24.7B ▲ | $14.89B ▲ | $9.77B ▲ |
| Q3-2025 | $1.96B ▲ | $23.9B ▲ | $14.14B ▼ | $9.72B ▲ |
| Q2-2025 | $1.92B ▲ | $23.74B ▲ | $14.39B ▲ | $9.32B ▲ |
| Q1-2025 | $1.16B ▼ | $22.37B ▼ | $13.46B ▼ | $8.88B ▲ |
| Q4-2024 | $1.26B | $22.39B | $13.6B | $8.76B |
What's financially strong about this company?
The company has a long track record of profits, positive equity, and a solid investment in physical assets. Debt is mostly long-term, and inventory is under control.
What are the financial risks or weaknesses?
Cash reserves have dropped sharply, making liquidity tight. Over half of assets are goodwill and intangibles, which could be written down if acquisitions underperform.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $568.6M ▼ | $1.09B ▲ | $-1.98B ▼ | $-431.6M ▲ | $-1.31B ▼ | $758M ▲ |
| Q3-2025 | $589.7M ▲ | $791.3M ▲ | $-280.6M ▼ | $-477.4M ▼ | $34.9M ▼ | $529.7M ▲ |
| Q2-2025 | $528.5M ▲ | $701.8M ▲ | $-224.4M ▼ | $297.3M ▲ | $758.3M ▲ | $485.1M ▲ |
| Q1-2025 | $406.5M ▼ | $369.4M ▼ | $-224M ▲ | $-241.6M ▼ | $-94.2M ▼ | $131.5M ▼ |
| Q4-2024 | $492.4M | $766.7M | $-627.5M | $-140.1M | $-4.3M | $407M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Global Institutional and Specialty | $1.42Bn ▲ | $1.54Bn ▲ | $1.59Bn ▲ | $1.55Bn ▼ |
Global Life Sciences | $170.00M ▲ | $190.00M ▲ | $180.00M ▼ | $210.00M ▲ |
Global Pest Elimination | $280.00M ▲ | $320.00M ▲ | $330.00M ▲ | $320.00M ▼ |
Global Water | $1.83Bn ▲ | $1.98Bn ▲ | $2.05Bn ▲ | $2.12Bn ▲ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Asia Pacific | $310.00M ▲ | $330.00M ▲ | $340.00M ▲ | $380.00M ▲ |
C N | $170.00M ▲ | $180.00M ▲ | $180.00M ▲ | $180.00M ▲ |
CANADA | $110.00M ▲ | $120.00M ▲ | $130.00M ▲ | $130.00M ▲ |
Europe | $710.00M ▲ | $810.00M ▲ | $860.00M ▲ | $890.00M ▲ |
Latin America | $250.00M ▲ | $260.00M ▲ | $280.00M ▲ | $310.00M ▲ |
Middle East and Africa | $130.00M ▲ | $160.00M ▲ | $160.00M ▲ | $190.00M ▲ |
UNITED STATES | $2.00Bn ▲ | $2.15Bn ▲ | $2.21Bn ▲ | $2.12Bn ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Ecolab Inc.'s financial evolution and strategic trajectory over the past five years.
Ecolab combines steady, broad-based revenue growth with improving profitability and strong cash generation. Its business model blends consumables, equipment, digital tools, and on-site service into a highly sticky offering with high switching costs. The company has a leading global position in essential areas such as water management, hygiene, and infection prevention, and it is building strong platforms in life sciences, microelectronics, and data centers. The balance sheet benefits from growing retained earnings and equity, and the cash flow statement shows an ability to fund substantial growth investments while consistently returning capital to shareholders.
Key risks center on financial leverage, liquidity, and execution. Net debt has risen recently and cash balances have fallen, while short-term obligations have grown faster than liquid assets, tightening the liquidity profile. EBITDA volatility and a slight dip in net income in the latest year hint at susceptibility to non-operating factors or one-off shocks. Heavy use of acquisitions and the buildup of goodwill create integration risk and potential for future write-downs if deals underperform. The apparent elimination of reported R&D spending, despite an innovation-heavy strategy, raises questions about the sustainability and transparency of internal development efforts. Finally, exposure to cyclical and regulated industries means that macroeconomic downturns and regulatory shifts can meaningfully affect demand and costs.
Taken together, Ecolab appears positioned for continued long-term growth, supported by structural demand for cleaner, safer, and more resource-efficient operations across many industries. Its strong competitive moat, digital and sustainability focus, and presence in high-growth sectors provide a solid foundation. However, the more aggressive capital deployment of recent years—through higher capex, acquisitions, and large buybacks—combined with weaker liquidity and higher net debt, increases the importance of disciplined execution and careful risk management. Future results will likely hinge on the company’s ability to translate its innovation pipeline and strategic acquisitions into sustained margin expansion and robust cash flows while gradually rebuilding financial flexibility.
About Ecolab Inc.
https://www.ecolab.comEcolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $4.2B ▲ | $1.06B ▼ | $563.9M ▼ | 13.44% ▼ | $2 ▼ | $903.4M ▲ |
| Q3-2025 | $4.17B ▲ | $1.11B ▲ | $585M ▲ | 14.05% ▲ | $2.06 ▲ | $789M ▼ |
| Q2-2025 | $4.03B ▲ | $1.09B ▲ | $524.2M ▲ | 13.02% ▲ | $1.85 ▲ | $977.8M ▲ |
| Q1-2025 | $3.69B ▼ | $1.05B ▼ | $402.5M ▼ | 10.89% ▼ | $1.42 ▼ | $818.2M ▼ |
| Q4-2024 | $4.01B | $1.05B | $472.9M | 11.81% | $1.67 | $848.5M |
What's going well?
The company is keeping revenue stable and managing costs well, with operating expenses down and operating profit up. Interest costs are falling, and the business remains solidly profitable.
What's concerning?
Gross margins are slipping, and net income is down despite cost cuts. Growth is nearly flat, and higher 'other' expenses are weighing on the bottom line.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $646.2M ▼ | $24.7B ▲ | $14.89B ▲ | $9.77B ▲ |
| Q3-2025 | $1.96B ▲ | $23.9B ▲ | $14.14B ▼ | $9.72B ▲ |
| Q2-2025 | $1.92B ▲ | $23.74B ▲ | $14.39B ▲ | $9.32B ▲ |
| Q1-2025 | $1.16B ▼ | $22.37B ▼ | $13.46B ▼ | $8.88B ▲ |
| Q4-2024 | $1.26B | $22.39B | $13.6B | $8.76B |
What's financially strong about this company?
The company has a long track record of profits, positive equity, and a solid investment in physical assets. Debt is mostly long-term, and inventory is under control.
What are the financial risks or weaknesses?
Cash reserves have dropped sharply, making liquidity tight. Over half of assets are goodwill and intangibles, which could be written down if acquisitions underperform.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $568.6M ▼ | $1.09B ▲ | $-1.98B ▼ | $-431.6M ▲ | $-1.31B ▼ | $758M ▲ |
| Q3-2025 | $589.7M ▲ | $791.3M ▲ | $-280.6M ▼ | $-477.4M ▼ | $34.9M ▼ | $529.7M ▲ |
| Q2-2025 | $528.5M ▲ | $701.8M ▲ | $-224.4M ▼ | $297.3M ▲ | $758.3M ▲ | $485.1M ▲ |
| Q1-2025 | $406.5M ▼ | $369.4M ▼ | $-224M ▲ | $-241.6M ▼ | $-94.2M ▼ | $131.5M ▼ |
| Q4-2024 | $492.4M | $766.7M | $-627.5M | $-140.1M | $-4.3M | $407M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Global Institutional and Specialty | $1.42Bn ▲ | $1.54Bn ▲ | $1.59Bn ▲ | $1.55Bn ▼ |
Global Life Sciences | $170.00M ▲ | $190.00M ▲ | $180.00M ▼ | $210.00M ▲ |
Global Pest Elimination | $280.00M ▲ | $320.00M ▲ | $330.00M ▲ | $320.00M ▼ |
Global Water | $1.83Bn ▲ | $1.98Bn ▲ | $2.05Bn ▲ | $2.12Bn ▲ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Asia Pacific | $310.00M ▲ | $330.00M ▲ | $340.00M ▲ | $380.00M ▲ |
C N | $170.00M ▲ | $180.00M ▲ | $180.00M ▲ | $180.00M ▲ |
CANADA | $110.00M ▲ | $120.00M ▲ | $130.00M ▲ | $130.00M ▲ |
Europe | $710.00M ▲ | $810.00M ▲ | $860.00M ▲ | $890.00M ▲ |
Latin America | $250.00M ▲ | $260.00M ▲ | $280.00M ▲ | $310.00M ▲ |
Middle East and Africa | $130.00M ▲ | $160.00M ▲ | $160.00M ▲ | $190.00M ▲ |
UNITED STATES | $2.00Bn ▲ | $2.15Bn ▲ | $2.21Bn ▲ | $2.12Bn ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Ecolab Inc.'s financial evolution and strategic trajectory over the past five years.
Ecolab combines steady, broad-based revenue growth with improving profitability and strong cash generation. Its business model blends consumables, equipment, digital tools, and on-site service into a highly sticky offering with high switching costs. The company has a leading global position in essential areas such as water management, hygiene, and infection prevention, and it is building strong platforms in life sciences, microelectronics, and data centers. The balance sheet benefits from growing retained earnings and equity, and the cash flow statement shows an ability to fund substantial growth investments while consistently returning capital to shareholders.
Key risks center on financial leverage, liquidity, and execution. Net debt has risen recently and cash balances have fallen, while short-term obligations have grown faster than liquid assets, tightening the liquidity profile. EBITDA volatility and a slight dip in net income in the latest year hint at susceptibility to non-operating factors or one-off shocks. Heavy use of acquisitions and the buildup of goodwill create integration risk and potential for future write-downs if deals underperform. The apparent elimination of reported R&D spending, despite an innovation-heavy strategy, raises questions about the sustainability and transparency of internal development efforts. Finally, exposure to cyclical and regulated industries means that macroeconomic downturns and regulatory shifts can meaningfully affect demand and costs.
Taken together, Ecolab appears positioned for continued long-term growth, supported by structural demand for cleaner, safer, and more resource-efficient operations across many industries. Its strong competitive moat, digital and sustainability focus, and presence in high-growth sectors provide a solid foundation. However, the more aggressive capital deployment of recent years—through higher capex, acquisitions, and large buybacks—combined with weaker liquidity and higher net debt, increases the importance of disciplined execution and careful risk management. Future results will likely hinge on the company’s ability to translate its innovation pipeline and strategic acquisitions into sustained margin expansion and robust cash flows while gradually rebuilding financial flexibility.

CEO
Christophe Beck
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2003-06-09 | Forward | 2:1 |
| 1998-01-16 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 776
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Evercore ISI Group
Outperform
BMO Capital
Outperform
Exane BNP Paribas
Outperform
BNP Paribas
Outperform
Citigroup
Buy
Jefferies
Buy
Grade Summary
Showing Top 6 of 16
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:25.33M
Value:$7.81B
BLACKROCK, INC.
Shares:22.64M
Value:$6.98B
BLACKROCK INC.
Shares:21.75M
Value:$6.71B
Summary
Showing Top 3 of 2,195

